δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation

As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Huang, Fei, Chen, Junying, Lan, Ruilong, Wang, Zeng, Chen, Ruiqing, Lin, Jingan, Zhang, Lurong, Fu, Lengxi
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136873/
https://ncbi.nlm.nih.gov/pubmed/30221043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450713
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky